Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1933340 | Biochemical and Biophysical Research Communications | 2009 | 6 Pages |
Abstract
CD26 binds to caveolin-1 in antigen-presenting cells (APC), and that ligation of CD26 by caveolin-1 induces T cell proliferation in a TCR/CD3-dependent manner. We report herein the effects of CD26–caveolin-1 costimulatory blockade by fusion protein caveolin-1-Ig (Cav-Ig). Soluble Cav-Ig inhibits T cell proliferation and cytokine production in response to recall antigen, or allogeneic APC. Our data hence suggest that blocking of CD26-associated signaling by soluble Cav-Ig may be an effective approach as immunosuppressive therapy.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Kei Ohnuma, Masahiko Uchiyama, Ryo Hatano, Wataru Takasawa, Yuko Endo, Nam H. Dang, Chikao Morimoto,